You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Secondary Angiosarcoma

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Secondary Angiosarcoma, Locally Advanced Sarcoma, Metastasis Trial in Nijmegen (Cemiplimab)

Recruiting
  • Secondary Angiosarcoma
  • +2 more
  • Nijmegen, Netherlands
    RadboudUMC
Jan 19, 2022

Angiosarcoma Trial in Houston (Paclitaxel, mRNA plus Lysate-loaded Dendritic Cell Vaccine, PEGYLATED-INTERFERON ALPHA-2A)

Not yet recruiting
  • Angiosarcoma
  • Houston, Texas
    M D Anderson Cancer Center
Mar 23, 2023

Angiosarcoma Trial in Austria, Germany (Pazopanib + Paclitaxel)

Terminated
Has Results
  • Angiosarcoma
  • Pazopanib + Paclitaxel
  • Graz, Austria
  • +9 more
Jan 21, 2022

Locally Advanced Angiosarcoma, Metastatic Angiosarcoma, Recurrent Angiosarcoma Trial in Houston (Quality-of-Life Assessment,

Recruiting
  • Locally Advanced Angiosarcoma
  • +2 more
  • Quality-of-Life Assessment
  • Sintilimab
  • Houston, Texas
    M D Anderson Cancer Center
Jul 31, 2022

Soft Tissue Sarcoma Adult, Angiosarcoma, Undifferentiated Pleomorphic Sarcoma Trial in Denmark, Norway, Sweden (Propranolol,

Recruiting
  • Soft Tissue Sarcoma Adult
  • +2 more
  • Aarhus, Denmark
  • +3 more
Jul 23, 2023

Adult Angiosarcoma, Recurrent Adult Soft Tissue Sarcoma, Stage III Adult Soft Tissue Sarcoma Trial in United States (drug,

Completed
Has Results
  • Adult Angiosarcoma
  • +3 more
  • pazopanib hydrochloride
  • +4 more
  • Chicago, Illinois
  • +4 more
Jul 26, 2022

Adult Angiosarcoma, Recurrent Adult Soft Tissue Sarcoma, Stage III Adult Soft Tissue Sarcoma Trial in United States

Completed
Has Results
  • Adult Angiosarcoma
  • +3 more
  • Santa Monica, California
  • +6 more
Mar 29, 2022

Skin Angiosarcoma, Skin Radiation-Related Angiosarcoma, Visceral Angiosarcoma Trial in Guam, United States (drug, biological,

Active, not recruiting
  • Skin Angiosarcoma
  • +2 more
  • Cabozantinib S-malate
  • +4 more
  • Phoenix, Arizona
  • +171 more
Dec 28, 2022

Angiosarcoma of Skin Trial in Worldwide (Oraxol)

Active, not recruiting
  • Angiosarcoma of Skin
  • New York, New York
  • +9 more
Jan 31, 2023

Advanced Soft Tissue Sarcoma, Locally Advanced Angiosarcoma, Locally Advanced Leiomyosarcoma Trial in Portland (Doxorubicin

Active, not recruiting
  • Advanced Soft Tissue Sarcoma
  • +26 more
  • Doxorubicin Hydrochloride
  • +3 more
  • Portland, Oregon
    OHSU Knight Cancer Institute
Jan 6, 2023

Malignant Melanoma, Angiosarcoma Trial in Chuo Ku (CICS-1 (investigational device),SPM-011(investigational drug))

Active, not recruiting
  • Malignant Melanoma
  • Angiosarcoma
  • CICS-1 (investigational device),SPM-011(investigational drug)
  • Chuo Ku, Tokyo, Japan
    National Cancer Center Hospital
Nov 6, 2022

Hepatic Small Vessel Neoplasm

Not yet recruiting
  • Hepatic Small Vessel Neoplasm
  • Imaging
  • (no location specified)
Oct 2, 2023

Angiosarcoma Metastatic Trial in Guangzhou (Abraxane combined with liposomal doxorubicin)

Recruiting
  • Angiosarcoma Metastatic
  • Abraxane combined with liposomal doxorubicin
  • Guangzhou, Guangdong, China
    Xing Zhang
Sep 4, 2022

Microvessel Ultrasound Imaging for Detecting Extent of Disease

Recruiting
  • Skin Angiosarcoma
  • Ultrasound Microvessel Imaging
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Feb 14, 2023

Angiosarcoma of Skin Trial in Tampa (T-VEC)

Active, not recruiting
  • Angiosarcoma of Skin
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
Mar 22, 2022

Unresectable Angiosarcoma Trial in Tokyo (BNCT)

Recruiting
  • Unresectable Angiosarcoma
  • BNCT
  • Tokyo, Japan
    National Cancer Center Hospital
Nov 21, 2022

Angiosarcoma, Epithelioid Hemangioendothelioma Trial in Boston (Eribulin)

Recruiting
  • Angiosarcoma
  • Epithelioid Hemangioendothelioma
  • Boston, Massachusetts
  • +1 more
Feb 14, 2022

Angiosarcoma Trial in Amsterdam (Propranolol)

Recruiting
  • Angiosarcoma
  • Amsterdam, Netherlands
    Netherlands Cancer Institute - Antoni van Leeuwenhoek
Dec 20, 2021

Angiosarcoma Trial (AGEN2034, AGEN1884)

Withdrawn
  • Angiosarcoma
  • (no location specified)
Dec 21, 2021

Advanced Soft Tissue Sarcoma Trial in United States (TRC105 and Pazopanib)

Completed
Has Results
  • Advanced Soft Tissue Sarcoma
  • TRC105 and Pazopanib
  • Birmingham, Alabama
  • +8 more
May 11, 2020

Advanced Angiosarcoma Trial in Worldwide (TRC105, Votrient)

Completed
Has Results
  • Advanced Angiosarcoma
  • Tucson, Arizona
  • +38 more
May 11, 2020

Metastatic Angiosarcoma, Metastatic Dedifferentiated Liposarcoma, Metastatic Osteosarcoma Trial in Houston (Durvalumab,

Recruiting
  • Metastatic Angiosarcoma
  • +7 more
  • Durvalumab
  • Oleclumab
  • Houston, Texas
    M D Anderson Cancer Center
Sep 21, 2021

Type 2 Diabetes Trial in Worldwide (HOE901-U300 (new formulation of insulin glargine), Lantus (insulin glargine))

Completed
Has Results
  • Type 2 Diabetes Mellitus
  • HOE901-U300 (new formulation of insulin glargine)
  • Lantus (insulin glargine)
  • Chandler, Arizona
  • +192 more
Mar 15, 2022

Soft Tissue Sarcoma Trial in United Kingdom (Axitinib)

Completed
  • Soft Tissue Sarcoma
  • Aberdeen, Scotland, United Kingdom
  • +12 more
Mar 17, 2021

Sarcoma Trial in United Kingdom (radiotherapy)

Completed
  • Sarcoma
  • radiotherapy
  • Birmingham, England, United Kingdom
  • +5 more
Mar 17, 2021